INHIBITOR OF ATR (ATAXIA TELANGIECTASIA AND RAD 3 RELATED) KINASE

被引：0
|
作者：
Plummer, E. R. [1 ]
机构：
[1] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] Design, Synthesis, and Biological Evaluation of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3-Related (ATR) Kinase for the Efficient Treatment of Cancer
    Shao, Jialu
    Huang, Lei
    Lai, Wenwen
    Zou, Yi
    Zhu, Qihua
    MOLECULES, 2023, 28 (11):
  • [32] Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma
    Karukonda, Pooja
    Odhiambo, Diana
    Mowery, Yvonne M.
    MOLECULAR CARCINOGENESIS, 2022, 61 (02) : 225 - 238
  • [33] A splicing mutation affecting expression of ataxia–telangiectasia and Rad3–related protein (ATR) results in Seckel syndrome
    Mark O'Driscoll
    Victor L. Ruiz-Perez
    C. Geoffrey Woods
    Penny A. Jeggo
    Judith A. Goodship
    Nature Genetics, 2003, 33 : 497 - 501
  • [34] Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
    Talele, Surabhi
    Zhang, Wenjuan
    Burgenske, Danielle M.
    Kim, Minjee
    Mohammad, Afroz S.
    Dragojevic, Sonja
    Gupta, Shiv K.
    Bindra, Ranjit S.
    Sarkaria, Jann N.
    Elmquist, William F.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 379 (03): : 343 - 357
  • [35] Pharmacokinetic (PK) profile and food effect of RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase in patients (pts) with cancer
    Lheureux, S.
    Rosen, E.
    Lee, E.
    Spigel, D.
    Hojgaard, M.
    Fontana, E.
    Mettu, N. B.
    Carter, L.
    Patel, S.
    Papp, R.
    May, S.
    Nejad, P.
    Ulanet, D.
    Wainszelbaum, M.
    Manley, P.
    Koehler, M.
    Fretland, A. J.
    Plummer, R.
    Yap, T. A.
    ANNALS OF ONCOLOGY, 2022, 33 : S4 - S5
  • [36] Quantitative Phosphoproteomics of the Ataxia Telangiectasia-Mutated (ATM) and Ataxia Telangiectasia-Mutated and Rad3-related (ATR) Dependent DNA Damage Response in Arabidopsis thaliana
    Roitinger, Elisabeth
    Hofer, Manuel
    Koecher, Thomas
    Pichler, Peter
    Novatchkova, Maria
    Yang, Jianhua
    Schloegelhofer, Peter
    Mechtler, Karl
    MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (03) : 556 - 571
  • [37] First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors
    Yap, Timothy A.
    Tolcher, Anthony W.
    Plummer, Ruth
    Mukker, Jatinder Kaur
    Enderlin, Marta
    Hicking, Christine
    Grombacher, Thomas
    Locatelli, Giuseppe
    Szucs, Zoltan
    Gounaris, Ioannis
    de Bono, Johann S.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2057 - 2067
  • [38] Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells
    Sultana, Rebeka
    Abdel-Fatah, Tarek
    Perry, Christina
    Moseley, Paul
    Albarakti, Nada
    Mohan, Vivek
    Seedhouse, Claire
    Chan, Stephen
    Madhusudan, Srinivasan
    PLOS ONE, 2013, 8 (02):
  • [39] ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is activated by mild hypothermia in mammalian cells and subsequently activates p53
    Roobol, Anne
    Roobol, Jo
    Carden, Martin J.
    Bastide, Amandine
    Willis, Anne E.
    Dunn, Warwick B.
    Goodacre, Royston
    Smales, C. Mark
    BIOCHEMICAL JOURNAL, 2011, 435 : 499 - 508
  • [40] Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
    Fontana, Elisa
    Rosen, Ezra
    Lee, Elizabeth K.
    Hojgaard, Martin
    Mettu, Niharika B.
    Lheureux, Stephanie
    Carneiro, Benedito A.
    Cote, Gregory M.
    Carter, Louise
    Plummer, Ruth
    Mahalingam, Devalingam
    Fretland, Adrian J.
    Schonhoft, Joseph D.
    Silverman, Ian M.
    Wainszelbaum, Marisa
    Xu, Yi
    Ulanet, Danielle
    Koehler, Maria
    Yap, Timothy A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (09):
12345